M Tiikkainen, AM Häkkinen, E Korsheninnikova … - Diabetes, 2004 - Am Diabetes Assoc Both rosiglitazone and metformin increase hepatic insulin sensitivity, but their
mechanism of action has not been compared in humans. The objective of this study
was to compare the effects of rosiglitazone and metformin treatment on ... Cited by 276 - Related articles - BL Direct - All 6 versions
E Bugianesi, E Gentilcore, R Manini, S Natale … - American journal of gastroenterology, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 269 - Related articles - All 4 versions
DG Carey, GJ Cowin, GJ Galloway, NP Jones, … - Obesity, 2002 - nature.com Results: There was a significant improvement in glycemic control (glycosylated
hemoglobin -0.7 0.7%, p 0.05) and an 86% increase in insulin sensitivity in the
RSG group (glucose-disposal rate change from baseline: 17.5 14.5 mol ... Cited by 130 - Related articles - All 3 versions
M Bajaj, S Suraamornkul, T Pratipanawatr, LJ … - Diabetes, 2003 - Am Diabetes Assoc The effect of pioglitazone on splanchnic glucose uptake (SGU), endogenous
glucose production (EGP), and hepatic fat content was studied in 14 type 2
diabetic patients (age 50 ± 2 years, BMI 29.4 ± 1.1 kg/m 2 , HbA 1c 7.8 ... Cited by 165 - Related articles - BL Direct - All 4 versions
R Belfort, SA Harrison, K Brown, C Darland, J … - New England Journal of Medicine, 2006 - content.nejm.org Methods We randomly assigned 55 patients with impaired glucose tolerance or type
2 diabetes and liver biopsy–confirmed nonalcoholic steatohepatitis to 6 months
of treatment with a hypocaloric diet (a reduction of 500 kcal per day in ... Cited by 380 - Related articles - BL Direct - All 7 versions
- ►endojournals.org M Bajaj, S Suraamornkul, P Piper, LJ Hardies … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc The effect of pioglitazone (PIO) on plasma adiponectin concentration, endogenous
glucose production (EGP), and hepatic fat content (HFC) was studied in 11 type 2
diabetic patients (age, 52 ± 2 yr; body mass index, 29.6 ± 1.1 kg/m 2 ; ... Cited by 211 - Related articles - BL Direct - All 6 versions
AB Mayerson, RS Hundal, S Dufour, V Lebon, … - Diabetes, 2002 - Am Diabetes Assoc We examined the effect of three months of rosiglitazone treatment (4 mg bid) on
whole-body insulin sensitivity and in vivo peripheral adipocyte insulin
sensitivity as assessed by glycerol release in microdialysis from ... Cited by 418 - Related articles - BL Direct - All 4 versions
S Nair, AM Diehl, M Wiseman, GH Farr, RP … - Alimentary Pharmacology and Therapeutics, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 177 - Related articles - BL Direct - All 5 versions
A Uygun, A Kadayifci, AT Isik, T Ozgurtas, S … - Alimentary Pharmacology and Therapeutics, 2004 - medscape.com Ongoing studies and current reports have focused on the role of
hyperinsulinaemia and increased insulin resistance as major pathogenic factors
in the development of non-alcoholic steatohepatitis. [7,8] On the basis of ... Cited by 199 - Related articles - BL Direct - All 10 versions
BA Neuschwander-Tetri, EM Brunt, KR … - Hepatology, 2003 - interscience.wiley.com Insulin resistance (IR) commonly is associated with nonalcoholic steatohepatitis
(NASH). To establish whether IR causes NASH, this study was undertaken to
determine if improving IR would improve the histologic features that define ... Cited by 513 - Related articles - All 6 versions
